These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 324670)

  • 1. E-rosette forming cell numbers in the blood of human renal allograft recipients.
    Kelly GE; Sheil AG
    Clin Exp Immunol; 1977 Mar; 27(3):454-63. PubMed ID: 324670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active T and EA-rosette-forming cells in human cadaver renal allograft recipients.
    Sengar DP; Rashid A; Harris JE
    Clin Exp Immunol; 1979 Feb; 35(2):236-41. PubMed ID: 373936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring and modulation of recipient immune responsiveness to prevent kidney graft rejection in the early post-transplant period.
    Renna E; Sansonetti P; Nesci C; Famulari A; Cortesini R
    Proc Eur Dial Transplant Assoc; 1977; 14():336-41. PubMed ID: 341135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late acute rejection in long-term renal allograft recipients. Diagnostic and predictive value of circulating activated T cells.
    Reinke P; Fietze E; Döcke WD; Kern F; Ewert R; Volk HD
    Transplantation; 1994 Jul; 58(1):35-41. PubMed ID: 7913561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in peripheral blood T-cell rosettes in kidney allograft patients during the first postoperative month.
    Daudu P; Wright K; Geelhoed GW
    Am Surg; 1980 Dec; 46(12):697-707. PubMed ID: 7004286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total and active T cell dynamics in renal allograft recipients.
    Kerman RH; Geis WP
    Surgery; 1976 Apr; 79(4):398-407. PubMed ID: 769220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of 'TaqMan' RT-PCR and RT-PCR ELISA for immunological monitoring of renal transplant recipients.
    Gibbs PJ; Tan LC; Sadek SA; Howell WM
    Transpl Immunol; 2003; 11(1):65-72. PubMed ID: 12727477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transplant monitoring of renal allograft recipients for T, B and null lymphocyte subpopulations.
    Sengar DP; Rashid A; Harris JE
    Clin Exp Immunol; 1977 Apr; 28(1):123-9. PubMed ID: 140776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal anti-T12 antibody as therapy for renal allograft rejection.
    Carpenter CB; Milford EL; Reinherz EL; Schlossman SF; Tilney NL; Strom TB; Kirkman RL; Busch GJ; Araujo JL
    Trans Assoc Am Physicians; 1983; 96():84-92. PubMed ID: 6388105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful immunosuppression of renal allograft recipients with alternate day steroid therapy.
    Burleson RL; Scruggs BF; Brennan A
    Clin Nephrol; 1978 Sep; 10(3):87-9. PubMed ID: 359210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized clinical trial of antithymocyte globulin in cadaver renal allograft recipients: importance of T cell monitoring.
    Cosimi AB; Wortis HH; Delmonico FL; Russell PS
    Surgery; 1976 Aug; 80(2):155-63. PubMed ID: 781887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OKT3 escalating dose regimens provide effective therapy for renal allograft rejection.
    Woodle ES; Bruce DS; Josephson M; Cronin D; Newell KA; Millis JM; Piper JB; O'Laughlin R; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):389-95. PubMed ID: 8884115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Completely reversed acute rejection episodes do not influence the long-term renal allograft survival].
    Wu JY; Chen JH; Wang YM; Zhang JG; Zhu C; Wang SY; Zhang P; Huang HF; He Q
    Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(2):106-9. PubMed ID: 12812676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring immunosuppression following renal transplantation.
    Giorgi JV; Cosimi AB; Colvin RB; Goldstein G; Delmonico FL; Russell PS
    Diagn Immunol; 1983; 1(3):174-8. PubMed ID: 6388969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and alterations of lymphocyte subpopulations in renal allograft recipients.
    Chatterjee SN; Gershwin ME; Eckles D
    Transplant Proc; 1979 Mar; 11(1):374-8. PubMed ID: 377659
    [No Abstract]   [Full Text] [Related]  

  • 18. Monitoring and modulation of immune reactivity in human transplant recipients.
    Thomas F; Lee HM; Wolf JS; Mendez-Picon G; Thomas J
    Surgery; 1976 Apr; 79(4):408-13. PubMed ID: 769221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Banff borderline acute rejection among renal allograft recipients.
    Matoza JR; Danguilan RA; Chicano S
    Transplant Proc; 2008 Sep; 40(7):2303-6. PubMed ID: 18790219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
    Thervet E; Pfeffer P; Scolari MP; Toselli L; Pallardó LM; Chadban S; Pilmore H; Connolly J; Buchler M; Schena FP; Carreño CA; Dandavino R; Cole E
    Transplantation; 2003 Sep; 76(6):903-8. PubMed ID: 14508352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.